Doximity Income Statement
DOCS / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 7 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 37.4% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- Strong profit margin: 39.1%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | - | $570.4M | $475.4M | $419.1M | $343.5M | $206.9M | $116.4M |
| Cost of Revenue | - | $55.9M | $50.7M | $53.5M | $39.8M | $31.2M | $14.9M |
| Gross Profit | - | $514.5M | $424.8M | $365.6M | $303.8M | $175.7M | $101.5M |
| SG&A Expense | - | $45.7M | $37.8M | $36.7M | $35.7M | $16.5M | $7.4M |
| R&D Expense | - | $93.0M | $82.0M | $80.2M | $62.4M | $43.9M | $32.4M |
| Operating Income | - | $227.8M | $163.9M | $125.1M | $113.5M | $53.3M | $22.2M |
| Income Tax | - | $40.4M | $37.6M | $20.3M | -$40.8M | $7.6M | -$6.2M |
| Net Income | - | $223.2M | $147.6M | $112.8M | $154.8M | $50.2M | $29.7M |
| EPS (Basic) | $0.58 | $0.82 | $0.29 | $0.16 | $0.82 | $0.29 | $0.16 |
| EPS (Diluted) | $0.53 | $0.70 | $0.23 | $0.13 | $0.70 | $0.23 | $0.13 |
| Shares Outstanding | 186.6M | 193.9M | 192.4M | 82.9M | 191.0M | 95.1M | 81.7M |
| Gross Margin | - | 90.2% | 89.3% | 87.2% | 88.4% | 84.9% | 87.2% |
| Operating Margin | - | 39.9% | 34.5% | 29.9% | 33.0% | 25.8% | 19.0% |
| Profit Margin | - | 39.1% | 31.0% | 26.9% | 45.1% | 24.3% | 25.6% |